MX353955B - Hebras de acido hialuronico reticulado y metodos de uso de las mismas. - Google Patents

Hebras de acido hialuronico reticulado y metodos de uso de las mismas.

Info

Publication number
MX353955B
MX353955B MX2014004458A MX2014004458A MX353955B MX 353955 B MX353955 B MX 353955B MX 2014004458 A MX2014004458 A MX 2014004458A MX 2014004458 A MX2014004458 A MX 2014004458A MX 353955 B MX353955 B MX 353955B
Authority
MX
Mexico
Prior art keywords
threads
cross
hyaluronic acid
linked hyaluronic
methods
Prior art date
Application number
MX2014004458A
Other languages
English (en)
Other versions
MX2014004458A (es
Inventor
Fermanian Sara
Horne Kenneth
Shenoy Vivek
Rajadas Jayakumar
Prior Jeff
Jayakumar Naveen
Gurtner Geoffrey
Original Assignee
Allergan Holdings France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Holdings France Sas filed Critical Allergan Holdings France Sas
Publication of MX2014004458A publication Critical patent/MX2014004458A/es
Publication of MX353955B publication Critical patent/MX353955B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Artificial Filaments (AREA)
  • Cosmetics (AREA)

Abstract

Esta descripción se refiere de manera general a hebras con propiedades mejoradas que comprenden ácido hialurónico reticulado, a métodos optimizados para fabricar las hebras y a los usos de las mismas, por ejemplo, en aplicaciones estéticas (por ejemplo, definición del contorno facial, productos para el aumento de tejidos blandos), cirugía (por ejemplo, suturas), administración de fármacos, tratamientos de heridas con presión negativa, apósitos húmedos para heridas, y similares.
MX2014004458A 2011-10-11 2012-10-10 Hebras de acido hialuronico reticulado y metodos de uso de las mismas. MX353955B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161545962P 2011-10-11 2011-10-11
US201161568077P 2011-12-07 2011-12-07
US201261644945P 2012-05-09 2012-05-09
PCT/US2012/059618 WO2013055832A1 (en) 2011-10-11 2012-10-10 Threads of cross-linked hyaluronic acid and methods of use thereof

Publications (2)

Publication Number Publication Date
MX2014004458A MX2014004458A (es) 2014-09-22
MX353955B true MX353955B (es) 2018-02-07

Family

ID=47040838

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004458A MX353955B (es) 2011-10-11 2012-10-10 Hebras de acido hialuronico reticulado y metodos de uso de las mismas.

Country Status (12)

Country Link
US (2) US20130122068A1 (es)
EP (2) EP3243533B1 (es)
JP (1) JP6153529B2 (es)
KR (1) KR102049124B1 (es)
CN (1) CN104144714B (es)
AU (1) AU2012318283B2 (es)
CA (1) CA2852022A1 (es)
DK (1) DK2766056T3 (es)
ES (2) ES2823148T3 (es)
HK (1) HK1203855A1 (es)
MX (1) MX353955B (es)
WO (1) WO2013055832A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2658609T3 (es) 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
HUE049678T2 (hu) 2008-12-02 2020-10-28 Allergan Inc Injekciós eszköz
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US10028762B1 (en) 2013-10-14 2018-07-24 Percutaneous Cosmetic Devices LLC Method of cutting soft tissue under facial skin
WO2015112912A1 (en) 2014-01-27 2015-07-30 Allergan Holdings France S.A.S. Substance delivery device
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
US10226585B2 (en) 2014-10-01 2019-03-12 Allergan, Inc. Devices for injection and dosing
KR101693022B1 (ko) * 2014-10-21 2017-01-17 가톨릭관동대학교산학협력단 주름개선용 보형물
UA120637C2 (uk) * 2015-02-13 2020-01-10 Ендо Дерма Ко., Лтд. Мікроструктура, що використовує гідрогель зшитої гіалуронової кислоти, та спосіб її отримання
CA2976544A1 (en) 2015-03-10 2016-09-15 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
KR101709608B1 (ko) * 2015-09-03 2017-03-09 (주)진우바이오 용융 방사에 의한 히알루론산염 파이버의 제조방법 및 이로부터 제조된 히알루론산염 파이버
KR101784863B1 (ko) * 2015-09-03 2017-10-13 (주)진우바이오 히알루론산염이 코팅된 고 기능성 봉합사의 제조방법 및 이로부터 제조된 고 기능성 봉합사
CN105536064B (zh) * 2015-12-11 2018-10-26 成都青山利康药业有限公司 一种复合型软组织修复水凝胶及其制备方法和用途
EP3220273A1 (en) * 2016-03-17 2017-09-20 Tata Consultancy Services Limited Methods and systems for anomaly detection in a multithreaded application
EP4406569A2 (en) 2016-04-08 2024-07-31 Allergan, Inc. Aspiration and injection device
WO2018020501A1 (en) 2016-07-27 2018-02-01 Marbelle Threads Ltd. Threads of cross-linked hyaluronic acid and hydroxyapatite
EP3528858B1 (en) * 2016-10-18 2020-10-21 Aarhus Universitet Printed hyaluronic acid scaffolds
US10709444B2 (en) 2017-01-24 2020-07-14 Allergan Industrie Sas Thread insertion devices
US10258447B2 (en) 2017-01-24 2019-04-16 Allergan Industrie Sas Thread insertion devices
US10265151B2 (en) 2017-01-24 2019-04-23 Allergan Industrie Sas Thread insertion devices
US10820900B2 (en) 2017-01-24 2020-11-03 Allergan Industrie Sas Thread insertion devices
US10595977B2 (en) 2017-01-24 2020-03-24 Allergan Industrie, Sas Thread insertion devices
AU2018240375C1 (en) 2017-03-22 2024-02-01 Ascendis Pharma A/S Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
USD867582S1 (en) 2017-03-24 2019-11-19 Allergan, Inc. Syringe device
US10821205B2 (en) 2017-10-18 2020-11-03 Lifecell Corporation Adipose tissue products and methods of production
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en) * 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
ES2960617T3 (es) * 2017-10-19 2024-03-05 Lifecell Corp Productos de matriz de tejido acelular fluida y métodos de producción
KR102103180B1 (ko) * 2017-12-22 2020-04-22 케이비바이오메드 주식회사 히알루론산유도체, 플루란 및 카르복시메틸 셀룰로오스를 포함하는 유착방지용 조성물 및 이의 제조방법
WO2020234167A1 (en) * 2019-05-17 2020-11-26 ETH Zürich Printable hydrogel, method for generating a printable hydrogel, lyophilizate, printed product and 3d printing method
CA3142151A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant
US20220331260A1 (en) * 2020-06-01 2022-10-20 Lg Chem, Ltd. A method of preparing polymeric microparticles, polymeric microparticles, medical composition, cosmetic composition, medical articles and cosmetic articles using the same
CN113797382B (zh) * 2020-06-12 2022-09-09 四川大学 改性γ-聚谷氨酸凝胶止血材料及其制备方法和应用
KR102426699B1 (ko) 2020-11-26 2022-07-29 (주)진우바이오 히알루론산염 파이버 및 이의 제조방법
KR102596069B1 (ko) * 2020-12-21 2023-11-01 주식회사 엘앤씨바이오 진피조직 유래 세포외기질을 포함하는 창상 치료용 조성물 및 그 제조방법
CA3208574A1 (en) * 2021-02-16 2022-08-25 Prollenium Medical Technologies, Inc. Cross-linked ha beads, process for making same and uses
CN114351289B (zh) * 2021-12-31 2024-03-19 中国科学院苏州纳米技术与纳米仿生研究所 一种透明质酸纤维及其制备方法和应用
CN114732939A (zh) * 2022-04-20 2022-07-12 埃伦宝音 一种透明质酸线及其制备方法和用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US4969880A (en) 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
US5256418A (en) 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US5449383A (en) 1992-03-18 1995-09-12 Chatelier; Ronald C. Cell growth substrates
US5629186A (en) 1994-04-28 1997-05-13 Lockheed Martin Corporation Porous matrix and method of its production
US5578662A (en) 1994-07-22 1996-11-26 United States Surgical Corporation Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
CA2198243C (en) 1994-08-22 2007-06-26 Cesar Z. Lina Wound drainage equipment
FR2759576B1 (fr) * 1997-02-17 1999-08-06 Corneal Ind Implant de sclero-keratectomie pre-descemetique
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
AU2001285286A1 (en) * 2000-08-29 2002-03-13 Noveon Ip Holdings Corp. Hydrogels containing substances
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
US20050033362A1 (en) * 2001-09-13 2005-02-10 Grafton R. Donald High strength suture with collagen fibers
FR2898502B1 (fr) * 2006-03-16 2012-06-15 Sofradim Production Tissu prothetique tridimensionnel a face dense resorbable
JP4892679B2 (ja) * 2006-03-27 2012-03-07 国立大学法人弘前大学 ゲル紡糸によるヒアルロン酸繊維およびその製造方法
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2658609T3 (es) * 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
CA2757557C (en) * 2009-04-02 2017-06-27 Allergan, Inc. Hair-like shaped hydrogels for soft tissue augmentation
US20130142731A1 (en) * 2010-03-01 2013-06-06 Tau Tona Group LP Threads of cross-linked hyaluronic acid and methods of use thereof
CA2794254C (en) * 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
EP2979709B1 (en) * 2010-10-20 2017-08-02 Allergan Holdings France S.A.S. Threads of cross-linked hyaluronic acid and use thereof

Also Published As

Publication number Publication date
KR102049124B1 (ko) 2019-11-26
US20130226235A1 (en) 2013-08-29
AU2012318283A1 (en) 2013-05-09
DK2766056T3 (en) 2017-08-21
KR20140100469A (ko) 2014-08-14
CA2852022A1 (en) 2013-04-18
WO2013055832A1 (en) 2013-04-18
CN104144714A (zh) 2014-11-12
EP2766056B1 (en) 2017-06-28
CN104144714B (zh) 2016-10-19
ES2823148T3 (es) 2021-05-06
US20130122068A1 (en) 2013-05-16
MX2014004458A (es) 2014-09-22
JP2014533992A (ja) 2014-12-18
EP2766056A1 (en) 2014-08-20
EP3243533A1 (en) 2017-11-15
AU2012318283B2 (en) 2015-08-20
HK1203855A1 (en) 2015-11-06
EP3243533B1 (en) 2020-06-17
NZ623909A (en) 2016-09-30
ES2640267T3 (es) 2017-11-02
JP6153529B2 (ja) 2017-06-28

Similar Documents

Publication Publication Date Title
MX2014004458A (es) Hebra de acido hialuronico reticulado y metodos de uso de las mismas.
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
MX353942B (es) Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos.
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
WO2011148116A3 (fr) Acide hyaluronique modifie, procede de fabrication et utilisations
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
WO2011146926A3 (en) Systems and methods for treatment of sleep apnea
WO2014016816A3 (pt) Malha polímerica com permeabilidade seletiva, para a regeneraçâo/reparação de tecidos
TN2013000391A1 (en) Rolled collagen carrier
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
MX2014004994A (es) Cisteamina en el tratamiento de enfermedad fibrotica.
WO2012122081A3 (en) Dental treatment systems and uses thereof
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
GB201110777D0 (en) Methods and uses
WO2013055889A3 (en) Implantable scaffolds and methods of use
MX2015015379A (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
MX2021000583A (es) Producto de grafeno y usos terapeuticos del mismo.
MX2013002539A (es) Sobrenadante condicionado por leucocitos activados y usos para la cicatrizacion de heridas.
WO2011160082A3 (en) Therapeutic and cosmetic uses and applications of calreticulin
WO2011089531A3 (en) Effects of the association of vitamin k2 and vitamin d3 in the consolidation of a bone fracture
WO2014063035A3 (en) Treatment of pain using amnion derived adherent cells
MX2016007284A (es) Pelicula biodegradable de carboximetil quitosano y extracto etanólico de mimosa tenuiflora para el tratamiento de heridas.

Legal Events

Date Code Title Description
FG Grant or registration